Skip to main content

Advertisement

Log in

Obesity and Association of Serum 25(OH)D Levels with All-Cause Mortality

  • Original Research
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

Sequestration of vitamin D in adipose tissue is the main cause of the lower serum 25(OH)D levels in obese subjects. However, it remains unknown whether the adipose tissue stores of vitamin D are readily mobilized for meeting body needs. We aimed to examine whether the association between serum 25(OH)D and all-cause mortality differs by body weight. Using the computerized database of the largest health care provider in Israel, we identified a cohort of subjects ≥20-years old with serum 25(OH)D levels measured between January 2008 and December 2009. Mortality was ascertained through April-2013. Cox regression with restricted cubic-spline function was used to assess the association between serum 25(OH)D and mortality. Median follow-up was 48 months (IQR 43–53 months); 12,337 of 175,781 participants (7.0 %) died. The association between 25(OH)D and mortality was not linear (P < 0.001), and differed between BMI categories (P = 0.019). The lowest adjusted risk for mortality was observed at serum 25(OH)D levels of 73.0, 68.0, and 66.5 nmol/L among subjects with BMI <25, 25–29.9, and ≥30 kg/m2, respectively. Compared to reference level of 75 nmol/L, increased adjusted HR as evident by 95 % confidence interval lower bound >1.0 was observed at serum 25(OH)D levels less than; 61.0, 48.0, and 40.0 nmol/L among subjects with BMI <25, 25–29.9, and ≥30 kg/m2, respectively. Serum 25(OH)D levels associated with increased all-cause mortality were inversely related to BMI. However, this observational cohort study may still suffer from residual confounding; therefore, cause and effect relationship cannot be established from this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Holick MF (2009) Vitamin D deficiency. N Engl J Med 357:266–281

    Article  Google Scholar 

  2. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P; Morales-Torres J, IOF Committee of Scientific Advisors (CSA), Nutrition Working Group (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20:1807–1820

  3. Saliba W, Barnett O, Rennert HS, Rennert G (2012) The risk of all-cause mortality is inversely related to serum 25(OH)D levels. J Clin Endocrinol Metab 97:2792–2798

    Article  CAS  PubMed  Google Scholar 

  4. Holick MF (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353–373

    Article  CAS  PubMed  Google Scholar 

  5. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930

    Article  CAS  PubMed  Google Scholar 

  6. Pearce SH, Cheetham TD (2010) Diagnosis and management of vitamin D deficiency. BMJ 340:142–147

    CAS  Google Scholar 

  7. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA (2008) Serum 25-hydroxyvitamin D status of the US population: 1988–1994 compared with 2000–2004. Am J Clin Nutr 88:1519–1527

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Compston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TR (1981) Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 34:2359–2363

    CAS  PubMed  Google Scholar 

  9. Saliba W, Barnett-Griness O, Rennert G (2013) The relationship between obesity and the increase in serum 25(OH)D levels in response to vitamin D supplementation. Osteoporos Int 24:1447–1454

    Article  CAS  PubMed  Google Scholar 

  10. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S (1985) Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Investig 76:370–373

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Bolland MJ, Grey AB, Ames RW, Mason BH, Horne AM, Gamble GD, Reid IR (2007) The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency. Am J Clin Nutr 86:959–964

    CAS  PubMed  Google Scholar 

  12. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693

    CAS  PubMed  Google Scholar 

  13. National Academy of Science, Institute of Medicine. Dietary references intake for calcium and vitamin D. http://www.nap.edu/catalog.php?record_id=13050. Accessed 1 Sep 2011

  14. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Saliba W, Barnett O, Rennert HS, Lavi I, Rennert G (2011) The relationship between serum 25(OH)D and parathyroid hormone levels. Am J Med 124:1165–1170

    Article  CAS  PubMed  Google Scholar 

  16. Heinzl H, Kaider A (1997) Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed 54:201–208

    Article  CAS  PubMed  Google Scholar 

  17. Amrein K, Quraishi SA, Litonjua AA, Gibbons FK, Pieber TR, Camargo CA Jr, Giovannucci E, Christopher KB (2014) Evidence for a U-shaped relationship between pre-hospital vitamin D status and mortality: a cohort study. J Clin Endocrinol Metab 13:jc20133481 [Epub ahead of print]

  18. Sempos CT, Durazo-Arvizu RA, Dawson-Hughes B, Yetley EA, Looker AC, Schleicher RL, Cao G, Burt V, Kramer H, Bailey RL, Dwyer JT, Zhang X, Gahche J, Coates PM, Picciano MF (2013) Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the U.S. nationally representative NHANES. J Clin Endocrinol Metab 98:3001–3009

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Lin E, Armstrong-Moore D, Liang Z, Sweeney JF, Torres WE, Ziegler TR, Tangpricha V, Gletsu-Miller N (2011) Contribution of adipose tissue to plasma 25-hydroxyvitamin D concentrations during weight loss following gastric bypass surgery. Obesity 19:588–594

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Pramyothin P, Biancuzzo RM, Lu Z, Hess DT, Apovian CM, Holick MF (2011) Vitamin D in adipose tissue and serum 25-hydroxyvitamin D after Roux-en-Y gastric bypass. Obesity 19:2228–2234

    Article  CAS  PubMed  Google Scholar 

  21. Bruno C, Fulford AD, Potts JR, McClintock R, Jones R, Cacucci BM, Gupta CE, Peacock M, Considine RV (2010) Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin. J Clin Endocrinol Metab 95:159–166

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Aasheim ET, Björkman S, Søvik TT, Engström M, Hanvold SE, Mala T, Olbers T, Bøhmer T (2009) Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr 90:15–22

    Article  PubMed  Google Scholar 

  23. Johnson JM, Maher JW, DeMaria EJ, Downs RW, Wolfe LG, Kellum JM (2006) The long-term effects of gastric bypass on vitamin D metabolism. Ann Surg 243:701–704

    Article  PubMed Central  PubMed  Google Scholar 

  24. Saliba W, Rennert HS, Kershenbaum A, Rennert G (2012) Serum 25(OH)D concentrations in sunny Israel. Osteoporos Int 23:687–694

    Article  CAS  PubMed  Google Scholar 

  25. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 1:CD007470. doi:10.1002/14651858

  26. Bolland MJ, Grey A, Gamble GD, Reid IR (2014) The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2:307–320

    Article  CAS  PubMed  Google Scholar 

  27. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, Khan H, Baena CP, Prabhakaran D, Hoshen MB, Feldman BS, Pan A, Johnson L, Crowe F, Hu FB, Franco OH (2014) Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348:g1903. doi:10.1136/bmj.g1903

    Article  PubMed Central  PubMed  Google Scholar 

  28. Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults, 1999–2000. JAMA 9(288):1723–1727

    Article  Google Scholar 

  29. Ogden CL, Carroll MD, Kit BK, Flegal KM (2013) Prevalence of obesity among adults: united States, 2011–2012. NCHS Data Brief 131:1–8

    PubMed  Google Scholar 

Download references

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Walid Saliba.

Additional information

Walid Saliba, Ofra Barnett-Griness, and Gad Rennert declare no conflict of interest

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saliba, W., Barnett-Griness, O. & Rennert, G. Obesity and Association of Serum 25(OH)D Levels with All-Cause Mortality. Calcif Tissue Int 95, 222–228 (2014). https://doi.org/10.1007/s00223-014-9885-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-014-9885-0

Keywords

Navigation